B-2088

N/A

Report date: 2025/10/20 16:03:17
NME

Base Information

Drug NameB-2088
Drug Alias NameDorzidinB-2088
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarbapenem-Resistant InfectionKeratitisEnterobacteriaceae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSinSa Labs
China Registration ClassN/A

Develop Information

Active CompaniesSinSa Labs
Inactive CompaniesN/A
Active IndicationsKeratitis
Inactive IndicationsCarbapenem-Resistant InfectionEnterobacteriaceae Infections

Other Information

ATC CodeN/A
Related LinksN/A